- Home
- BKNG vs NVS Comparison
BKNG vs NVS Comparison
Compare BKNG & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKNG | NVS |
|---|---|---|
| Founded | 1997 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | 75267 |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.8B | 310.4B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | BKNG | NVS |
|---|---|---|
| Price | $4,323.86 | $155.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 29 | 4 |
| Target Price | ★ $5,886.00 | $118.00 |
| AVG Volume (30 Days) | 551.3K | ★ 2.4M |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | 0.96% | ★ 1.92% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 165.57 | N/A |
| Revenue | ★ $26,917,000,000.00 | N/A |
| Revenue This Year | $13.36 | $2.56 |
| Revenue Next Year | $8.53 | $4.91 |
| P/E Ratio | $26.48 | ★ $23.13 |
| Revenue Growth | ★ 13.39 | N/A |
| 52 Week Low | $3,765.45 | $97.72 |
| 52 Week High | $5,837.03 | $170.46 |
Technical Indicators
Market Signals| Indicator | BKNG | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 46.46 | 42.95 |
| Support Level | $3,765.45 | $113.19 |
| Resistance Level | $5,566.21 | $158.80 |
| Average True Range (ATR) | 142.32 | 2.44 |
| MACD | 61.93 | -1.63 |
| Stochastic Oscillator | 64.57 | 4.39 |
Price Performance
Historical ComparisonAbout BKNG Booking Holdings Inc.
Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airlines, rental cars, restaurants, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, Rentalcars.com, Kayak, and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.